Dr Eveline Hürlimann is a Senior Scientific Collaborator at the Swiss TPH. Her research interests include integrated control strategies against NTDs (mainly soil-transmitted helminths and schistosomiasis, diarrheal diseases) including WASH, community-directed approaches and combination therapy; clinical research and optimization of anthelminthic treatment against soil-transmitted helminths; and assessment of treatment benefits from regular deworming in endemic communities (clinically examined and self-reported) to advocate for more effective helminth control efforts and policy change
She has published >40 articles in the peer-reviewed literature, including 10 as first author. She has coordinated a 3-year multi-country randomized controlled trial in 3 developing countries including co-supervision of 3 PhD students and leading to more than 10 scientific articles, published or under review. Her work has contributed to the inclusion of a new indication for the administration of ivermectin in the essential medicines list of the World Health Organization for soil-transmitted helminth control. She was awarded the 9th Prix CSRS-Fond Eremitage 2017 for scientific research in partnership and the Anne Maurer Cecchini prize of 2022 for outstanding clinical or epidemiological research on one of the neglected tropical diseases in 2020 or 2021.
